Skip to content
★ Sign in to follow
FV

Flagship Ventures Fund 2004 L P

Related company / holding
Quanterix CorpHelicos Biosciences CorpTetraphase Pharmaceuticals IncDnib Unwind, Inc.Concert Pharmaceuticals, Inc.T2 Biosystems, Inc.
Total declarations
17
Companies
6
▲ Purchases (3 ops.)
€2.9M
▼ Sales (0 ops.)
—

Latest filing published 13 Dec 2017 for Quanterix Corp.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Flagship Ventures Fund 2004 L P: trading record in brief

This profile gathers the share dealings of Flagship Ventures Fund 2004 L P across 6 companies, led by Tetraphase Pharmaceuticals Inc, Quanterix Corp and Concert Pharmaceuticals, Inc. Over a trading history stretching from 18 September 2009 to 11 December 2017, the count stands at 17 filings.

On the market, this insider has only ever bought: 3 purchases, €2.9M in total. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The latest filing, published on 13 December 2017, reports a transaction in Quanterix Corp. The last purchase on record was published on 27 September 2013, which is 4,790 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Flagship Ventures Fund 2004 L P

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations